Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium SF Shariat, PI Karakiewicz, GS Palapattu, Y Lotan, CG Rogers, GE Amiel, ... The Journal of urology 176 (6), 2414-2422, 2006 | 844 | 2006 |
Prostate carcinogenesis and inflammation: emerging insights GS Palapattu, S Sutcliffe, PJ Bastian, EA Platz, AM De Marzo, WB Isaacs, ... Carcinogenesis 26 (7), 1170-1181, 2005 | 529 | 2005 |
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer ME Allaf, GS Palapattu, BJ Trock, HB Carter, PC Walsh The Journal of urology 172 (5), 1840-1844, 2004 | 425 | 2004 |
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy SF Shariat, GS Palapattu, PI Karakiewicz, CG Rogers, A Vazina, ... European urology 51 (1), 137-151, 2007 | 408 | 2007 |
The PSA−/lo prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration J Qin, X Liu, B Laffin, X Chen, G Choy, CR Jeter, T Calhoun-Davis, H Li, ... Cell stem cell 10 (5), 556-569, 2012 | 366 | 2012 |
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at … Y Lotan, A Gupta, SF Shariat, GS Palapattu, A Vazina, PI Karakiewicz, ... Journal of clinical oncology 23 (27), 6533-6539, 2005 | 345 | 2005 |
Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma GS Palapattu, B Kristo, J Rajfer Reviews in urology 4 (4), 163, 2002 | 304 | 2002 |
Nomograms provide improved accuracy for predicting survival after radical cystectomy SF Shariat, PI Karakiewicz, GS Palapattu, GE Amiel, Y Lotan, CG Rogers, ... Clinical Cancer Research 12 (22), 6663-6676, 2006 | 285 | 2006 |
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder PI Karakiewicz, SF Shariat, GS Palapattu, AE Gilad, Y Lotan, CG Rogers, ... The Journal of urology 176 (4), 1354-1362, 2006 | 249 | 2006 |
Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy PJ Bastian, GS Palapattu, X Lin, S Yegnasubramanian, LA Mangold, ... Clinical cancer research 11 (11), 4037-4043, 2005 | 249 | 2005 |
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy SF Shariat, PI Karakiewicz, R Ashfaq, SP Lerner, GS Palapattu, RJ Cote, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 228 | 2008 |
The role of sarcosine metabolism in prostate cancer progression AP Khan, TM Rajendiran, A Bushra, IA Asangani, JN Athanikar, ... Neoplasia 15 (5), 491-IN13, 2013 | 217 | 2013 |
Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis TR Kumar, G Palapattu, P Wang, TK Woodruff, I Boime, MC Byrne, ... Molecular endocrinology 13 (6), 851-865, 1999 | 215 | 1999 |
Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression N Putluri, A Shojaie, VT Vasu, SK Vareed, S Nalluri, V Putluri, ... Cancer research 71 (24), 7376-7386, 2011 | 211 | 2011 |
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder CG Rogers, GS Palapattu, SF Shariat, PI Karakiewicz, PJ Bastian, Y Lotan, ... The Journal of urology 175 (6), 2048-2053, 2006 | 210 | 2006 |
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma N Amara, GS Palapattu, M Schrage, Z Gu, GV Thomas, F Dorey, J Said, ... Cancer research 61 (12), 4660-4665, 2001 | 205 | 2001 |
Precystectomy nomogram for prediction of advanced bladder cancer stage PI Karakiewicz, SF Shariat, GS Palapattu, P Perrotte, Y Lotan, CG Rogers, ... European urology 50 (6), 1254-1262, 2006 | 189 | 2006 |
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy ME Nielsen, SF Shariat, PI Karakiewicz, Y Lotan, CG Rogers, GE Amiel, ... European urology 51 (3), 699-708, 2007 | 172 | 2007 |
Molecular biomarker in prostate cancer: the role of CpG island hypermethylation PJ Bastian, S Yegnasubramanian, GS Palapattu, CG Rogers, X Lin, ... European urology 46 (6), 698-708, 2004 | 169 | 2004 |
Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer GS Palapattu, C Wu, CR Silvers, HB Martin, K Williams, L Salamone, ... The Prostate 69 (7), 787-798, 2009 | 165 | 2009 |